Evidence map›Paper›PMID 36892687›Full record

ArticleJournal of clinical immunology2023

Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis.

Wenny Santaniemi, Pirjo Åström, Virpi Glumoff, Nora Pernaa, Ella-Noora Tallgren, Sanna Palosaari, Antti Nissinen, Meri Kaustio, Outi Kuismin, Janna Saarela and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Wenny SantaniemiResearch Unit of Biomedicine, University of Oulu, Oulu, Finland.
Pirjo ÅströmResearch Unit of Biomedicine, University of Oulu, Oulu, Finland.
Virpi GlumoffResearch Unit of Biomedicine, University of Oulu, Oulu, Finland.
Nora PernaaResearch Unit of Biomedicine, University of Oulu, Oulu, Finland.
Ella-Noora TallgrenResearch Unit of Biomedicine, University of Oulu, Oulu, Finland.
Sanna PalosaariCancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
Antti NissinenResearch Unit of Biomedicine, University of Oulu, Oulu, Finland.
Meri KaustioInstitute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.
Outi KuisminDepartment of Clinical Genetics, Oulu University Hospital, Oulu, Finland.
Janna SaarelaInstitute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.
Katariina NurmiFaculty of Medicine, Clinicum, Translational Immunology Program, University of Helsinki, Helsinki, Finland.
Kari K EklundDepartment of Rheumatology, Inflammation Center, University of Helsinki and Helsinki University Hospital and Orton Orthopedic Hospital, Helsinki, Finland.
Mikko R J SeppänenAdult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.
Timo HautalaResearch Unit of Biomedicine, University of Oulu, Oulu, Finland. timo.hautala@oulu.fi.ORCID 0000-0001-7889-1614
University of Oulu · FIUniversity of Helsinki · FIOulu University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loss-of-function (LOF) mutations in NFKB1, coding for p105, may cause common variable immunodeficiency due to dysregulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κΒ) pathway. Monoallelic LOF variants of NFKB1 can predispose to uncontrolled inflammation including sterile necrotizing fasciitis or pyoderma gangrenosum. In this study, we explored the impact of a heterozygous NFKB1 c.C936T/p.R157X LOF variant on immunity in sterile fasciitis patients and their family members. The p50 or p105 protein levels were reduced in all variant carriers. Interleukin-1β (IL-1β) and interleukin-8 (IL-8) levels were elevated in vitro, potentially contributing to the very high neutrophil counts observed during fasciitis episodes. Phosphorylation of p65/RelA was reduced in p.R157X neutrophils suggesting defective activation of canonical NF-κB. Oxidative burst after NF-κB-independent phorbol 12-myristate 13-acetate (PMA) stimulation was similar in both p.R157X and control neutrophils. Comparable amounts of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex subunits were found in p.R157X and control neutrophils. However, a compromised oxidative burst was observed in p.R157X neutrophils following activation of NF-κB-dependent mechanisms following stimulation of toll-like receptor 2 (TLR2) and Dectin-1. Neutrophil extracellular trap formation was not affected by p.R157X. In summary, the NFKB1 c.C936T/p.R157X LOF variant has an impact on inflammation and neutrophil function and may play a role in the pathogenesis of sterile necrotizing fasciitis.

Indexed as

Fasciitis, NecrotizingNF-kappa BHumansInflammationNeutrophilsNF-kappa B p50 SubunitRespiratory BurstNF-kappa BNF-kappa B p50 SubunitNFKB1 protein, humanInflammationInnate immunityNeutrophils

Identifiers

PMID36892687
PMCPMC10276129
OpenAlexW4323653722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.